Strategies for Maximizing Successful Drug Substance Technology Transfer Using Engineering, Shake-Down, and Wet Test Runs

Sushil Abraham; David Bain; John Bowers; Victor Larivee; Francisco Leira; Jasmina Xie

doi:10.5731/pdajpst.2015.01087

EditorialBPOG Special Section

Strategies for Maximizing Successful Drug Substance Technology Transfer Using Engineering, Shake-Down, and Wet Test Runs

Sushil Abraham, David Bain, John Bowers, Victor Larivee, Francisco Leira and Jasmina Xie

PDA Journal of Pharmaceutical Science and Technology September 2015, 69 (5) 650-657; DOI: https://doi.org/10.5731/pdajpst.2015.01087

Sushil Abraham

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

David Bain

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: david@biophorum.com

John Bowers

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Victor Larivee

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Francisco Leira

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jasmina Xie

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
References
Info & Metrics
PDF

Article Information

vol. 69 no. 5 650-657

DOI

https://doi.org/10.5731/pdajpst.2015.01087

PubMed

26429113

Published By

Parenteral Drug Association (PDA)

Print ISSN

1079-7440

Online ISSN

1948-2124

History

Published online October 1, 2015.

Author Information

Sushil Abraham
(Astra Zeneca)
,
David Bain
(Biophorum Operations Group)
*,
John Bowers
(Merck)
,
Victor Larivee
(Pfizer)
,
Francisco Leira
(Lonza)
and
Jasmina Xie
(Bayer)

↵*Corresponding Author: David Bain, Facilitator, BioPhorum Operations Group (BPOG) Corresponding author contact information: BPOG, 5 Westbrook Court, Sharrow Vale Road, Sheffield, S11 8YZ, United Kingdom. e-mail: david{at}biophorum.com

View Full Text

Cited By...

Citations
Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext

In This Issue

PDA Journal of Pharmaceutical Science and Technology

Vol. 69, Issue 5

September/October 2015

Table of Contents
Index by Author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Strategies for Maximizing Successful Drug Substance Technology Transfer Using Engineering, Shake-Down, and Wet Test Runs

Message Subject (Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology

Message Body (Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Math question * 1 + 4 =

Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Citation Tools

Strategies for Maximizing Successful Drug Substance Technology Transfer Using Engineering, Shake-Down, and Wet Test Runs

Sushil Abraham, David Bain, John Bowers, Victor Larivee, Francisco Leira, Jasmina Xie

PDA Journal of Pharmaceutical Science and Technology Sep 2015, 69 (5) 650-657; DOI: 10.5731/pdajpst.2015.01087

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Strategies for Maximizing Successful Drug Substance Technology Transfer Using Engineering, Shake-Down, and Wet Test Runs

Sushil Abraham, David Bain, John Bowers, Victor Larivee, Francisco Leira, Jasmina Xie

PDA Journal of Pharmaceutical Science and Technology Sep 2015, 69 (5) 650-657; DOI: 10.5731/pdajpst.2015.01087

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Data
References
Info & Metrics
PDF

No related articles found.

PubMed
Google Scholar

Cited By...

No citing articles found.

Google Scholar

BPOG Special Section

Changing the Performance Paradigm in Pharma/Biotech: Integrating Human Performance in Global Organizations
Overview of Best Practices for Biopharmaceutical Technology Transfers
Introduction to BioPhorum Operations Group (BPOG) Special Section Editorials

Show more BPOG Special Section

Editorial

Changing the Performance Paradigm in Pharma/Biotech: Integrating Human Performance in Global Organizations
Overview of Best Practices for Biopharmaceutical Technology Transfers
Introduction to BioPhorum Operations Group (BPOG) Special Section Editorials

Show more Editorial

Main menu

User menu

Search

Strategies for Maximizing Successful Drug Substance Technology Transfer Using Engineering, Shake-Down, and Wet Test Runs

Article Information

Author Information

Cited By...

In This Issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

BPOG Special Section

Editorial

Similar Articles

Readers

Author/Reviewer Information

Parenteral Drug Association, Inc.